News
Conservative oxygen therapy had no significant impact on 90-day all-cause mortality vs. usual oxygen therapy among ...
EMA’s CHMP issued an opinion not to recommend Elevidys™ (delandistrogene moxeparvovec) for the treatment of ambulatory individuals with Duchenne muscular dystrophy (DMD) Roche will continue its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback